Home | Business News | Browse by Publication | P | Pharma Marketletter

Cholesterol drugs "oversubscribed to millions of Americans".

Publication: Pharma Marketletter
Publication Date: 29-JAN-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
An article published in the peer-reviewed medical journal, The Lancet (January 20 issue), claims that cholesterol-lowering drugs are being over-prescribed and could spell big trouble for pharmaceutical companies such as Pfizer, maker of the best-selling medicine ever, Lipitor (atorvastatin), sales of which reached $12.89 billion for 2006 (see page 3).

The article, co-authored by Harvard Medical School clinical...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
S-P subsidiary fined $435.0M.(Schering-Plough Corp.)(Improperly market..., January 29, 2007
Stock Commentary - New York week to Aug 15.(stock index of biotechnolo..., January 29, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.